Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Cambridge, USA
840 Memorial Drive
Cambridge, MA, 02139


President & CEO
Vice President of Biology
Vice President of Finance
Board of Directors
Board of Directors
Board of Directors
Executive Vice President and Chief Operating Officer
Chief Scientific Officer
Show All People



Mersana Therapeutics

Mersana Therapeutics employs its biodegradable polymer platform (Fleximer®) to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. They also leverage the versatility of Fleximer through partnerships to overcome the safety, efficacy, and delivery challenges of nucleic acids, biologics, and small molecules in numerous therapeutic areas.

Recent Milestones



Mersana Therapeutics screenshot
Above: Mersana Therapeutics
Uploaded: 7/2/10


  1. Mersana Therapeutics, Inc. Completes $21 Million Financing ( [edit]
  2. SEC ( [edit]
  3. SEC ( [edit]
  4. Mersana Therapeutics Raises $27M in Series A-1 Financing ( [edit]
  5. SEC D/A ( [edit]
  6. Mersana appoints Bacopoulos to CEO post ( [edit]
Edit This Page
Last Edited 4/9/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy